Harm Reduction Briefing — Sep 15, 2026
NEWSLETTER UPDATE
Switch between daily and weekly versions of the newsletter. Search historical content with the search engine.
Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
📰 News Media
- 🏥 [National City, CA] Shuttered drug and alcohol treatment facility in National City to reopen - sandiegouniontribune.com
- 💊 [Aurora, Illinois] Kane County seeing fewer fatal opioid overdoses, as county prevention efforts continue - chicagotribune.com
- 🌿 [California] Teen cannabis surveys may be missing rise in diagnosed disorder, study of 637,000 adolescents finds - medicalxpress.com
- 💉 [National] Veterinary tranquilizer medetomidine leaves patients severely sedated and harder to treat for withdrawal - medicalxpress.com
- 💉 [National] Portugal decriminalized drugs 25 years ago, but the real lesson is what it built around this policy - theconversation.com
🗣️ Social Pulse
Lived/Living Experience
- No posts found today.
Innovation
- 🏥 The emergency room is the one door that can start treatment on the spot. In a randomized trial it did: buprenorphine begun in the ER, with 10-weeks of follow-on care arranged, and 78% were in treatment a month... - @rohitvangimalla on X
- 📊 CoRE has collected data from more than 6,000 people who started treatment through the Virtual Opioid Dependency Program. Early evidence indicates those receiving extended-release buprenorphine had better outcomes... - @RecovExcel on X
Opposition Views
🏙 City Updates
- No recent City Updates found.
📚 Academic Research
- 🧪 Justice Community Opioid Innovation Network (JCOIN) 1.0: Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Hub, Client Data, Connecticut and Texas, 2022-2025 - ICPSR Data Holdings - 2026-09-14 - doi.org
- 🤰 Utilizing a Standardized Bundle of Care to Improve Outcomes for Perinatal Patients with Substance Use Disorder: A Quality Improvement Project. - PubMed - 2026-09-14 - doi.org
- 🧪 Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan - Cureus - 2026-09-13 - doi.org
⚖️ Law & Policy
- No hits in Law and Policy today.
💸 Funding (Click to expand)
Current
- Deadline Approaching · 💊 Bureau of Justice Assistance - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program - Deadline: Sep 24, 2026
- Deadline Approaching · 🔬 National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
📣 Activism
- 📣 Mobilize Recovery - Contact your elected officials to support recovery and overdose prevention policies
- ✉️ National Council for Mental Wellbeing - Send a message to your Representative supporting the 988 Implementation Act
- 🗓️ Mobilize Recovery - RSVP for two virtual Mobilize Recovery advocacy and care events
Submit a Link
Click here to submit community content to the Harm Reduction Briefing
Featured Resource
Philadelphia Overdose Canvassing Report
See how Philadelphia employs trusted messengers, targeted outreach, supply kits, and same-day referrals to bring overdose prevention door to door.
Newsletter Improvements
September 13, 2026 (#5c603ea) - Testing navigation arrows. I love feedback and requests - [email protected]
Links
Don't miss what's next. Subscribe to Harm Reduction Briefing: